A synthetic peptide for use as a blocking control in assays to test for specificity of SCYE1 antibody, Alternative Names: SCYE1 control peptide, SCYE1 antibody Blocking Peptide, Anti-SCYE1 Blocking Peptide, Small Inducible Cytokine Subfamily E Member 1 Blocking Peptide, Endothelial Monocyte-Activating Blocking Peptide, AIMP1 Blocking Peptide, EMAP II Blocking Peptide, EMAP-2 Blocking Peptide, EMAP-II Blocking Peptide, EMAP2 Blocking Peptide, EMAPII Blocking Peptide, p43 Blocking Peptide, SCYE1, SCYE-1, SCYE 1, SCYE-1 Blocking Peptide, SCYE 1 Blocking Peptide
AIMP1
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP, BI
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
AIMP1
(Aminoacyl tRNA Synthetase Complex-Interacting Multifunctional Protein 1 (AIMP1))
Hintergrund
SCYE1 is a cytokine that is specifically induced by apoptosis. The release of this cytokine renders the tumor-associated vasculature sensitive to tumor necrosis factor. The precursor of SCYE1 (pro-SCYE1) is identical to the p43 subunit, which is associated with the multi-tRNA synthetase complex. Therefore, pro-SCYE1 may function in binding RNA as part of the tRNA synthetase complex in normal cells and in stimulating inflammatory responses after proteolytic cleavage in tumor cells.